Vaccine against HIV/AIDS

In collaboration with IrsiCaixa, the Institut de Recerca de la Sida [AIDS Research Institute] led by Doctor Bonaventura Clotet, advances have been made in research for a therapeutic vaccine to treat HIV/AIDS and reduce its related adverse effects. This initiative has also contributed to research into the influences of the microbiomes in the vaccine.

The study of the immune response in individuals with a high risk of being affected by AIDS assists in the development of strategies to prevent infection. In this regard, support has been given to studies to develop therapeutic vaccines for people who are HIV positive, while work is also being done in monoclonal antibodies that neutralise the action of the virus in the body, heightening the activity of natural killer (NK) cells destined to destroy other cells that have already been infected.

The Glòria Soler Foundation is part of the entities who supported the therapeutic vaccine HTI, at an important moment in development, and participates through IrsiCaixa in the SPIN OFF, Aelix Therapeutics S.L., created in 2016. In recognition, the foundation flaunts through IrsiCaixa a co-ownership percentage of 7,96%.

The company focuses on the discovery and development of immunotherapies against HIV infection. A first round of funding (11.5 million euros) was closed in January 2016. A phase II proof-of-concept clinical trial using the HTI immunogen as a therapeutic vaccine in people with HIV infection is foreseen to be completed by 2020.

World AIDS Day — 1 December

The Glòria Soler Foundation has given its support each 1 December, World AIDS Day, to the AIDS awareness campaign, illuminating the façade of its headquarters in red light.

Through its alliance with the Foundation for the Fight against AIDS, its collaboration in AIDS research is linked to its activity in social sensibility and awareness.

Art with the Fundació Suñol

Josep Carreras Foundation

Art and science with IDIBAPS

Pediatric Cancer Center Barcelona

Clínic Barcelona, in collaboration with the Glòria Soler Foundation, presents the documentary ARI. Una història d’amor i vida

The Glòria Soler Foundation together with the Suñol Foundation renew their commitment to art and science through the temporary transfer of the work of Eva Lootz

Beatriz Mothe and Lucía Bailón from IrsiCaixa receive the “European Hector Research Award in HIV 2023” for the research carried out on the therapeutic vaccine against HIV

The Glòria Soler Foundation collaborates in the 11th Nit de la Lluna Plena Solidarity Course in Sitges, contributing one euro for each participant

The Fundació Glòria Soler renews its collaboration agreement with the Josep Carreras Foundation